Episodebeskrivelse
Hunt, Mike, and Jason walk the Cash Flow Memo with oil back near $100, the 10-year above 5%, and the AI labs talking about extinction. Plus notes from the All-In Summit and a Vertex update.
The Cashflow Memo
Key Takeaways
* Hunt holds oil around $90 with the 12-month strip ~$20 lower despite WTI briefly topping $100; the real squeeze is diesel (~$200/bbl globally) from Ukrainian strikes on Russian refineries, Chinese product-export limits, and uninsurable Gulf product tankers.
* Gas has settled at ~$3.50 for both 2026 and 2027 as higher oil prices drive Permian associated-gas supply while power-sector demand stays flat on coal-plant life extensions and subsidized solar.
* With the 10-year above 5% and the Fed’s unanimous 25bp hike to 3.75-4%, Hunt still argues most investable assets belong in equities, about half in the leading dozen names, since the Mag 7 trades ~21x versus ~40x two years ago while growing sales at roughly 3x nominal GDP.
* Jason and Mike frame AI risk as an engineering problem (human gating, cyber rather than physical threat) and read the labs’ public doom talk as fundraising PR and a push for regulatory capture against open-source models; Anthropic told a small group of shareholders it expects positive adjusted operating income (excluding stock-based compensation) for a second straight quarter, per the FT.
* Jason sees the main threat to Vertex’s CF franchise receding after Sionna Therapeutics’ SION-719 missed its Phase 2a endpoint as a Trikafta add-on (Sionna is still advancing a dual combination), while non-opioid pain uptake improves and the FDA let Vertex add a blood-type-O second-generation T1D cell therapy as a new arm in the existing trial.
Show Notes
[00:27] Oil: the diesel squeeze Why the East-West pipeline shutdown and Hormuz headlines matter less for crude than for diesel, now ~$200/bbl worldwide, and why backwardation keeps the strip ~$20 under spot.
[05:15] Gas settles at $3.50 Higher oil prices mean more Permian associated gas, while flat power demand keeps prices anchored for 2026 and 2027.
[07:01] The 10-year above 5% A unanimous Fed hike, $2 trillion deficits, and hyperscaler debt push rates higher, yet the S&P trades 19x and the Mag 7 just 21x.
[10:59] Data center capacity is worth more than book Mike argues existing capacity is undervalued as new builds get harder and demand keeps rising.
[12:01] Engineering, not extinction Jason on why language models are software, where the real cyber risk sits, and why the labs’ doom talk looks like PR and a push to regulate open source out.
[20:08] Tap water, bottled water NVIDIA’s Hugging Face acquisition, Jensen’s All-In analogy for cheap versus premium intelligence, and whether hosted Grok agents replace always-on Mac minis.
[23:00] Healthcare: Vertex Sionna Therapeutics’ Phase 2a miss eases the competitive threat to Vertex’s cystic fibrosis franchise, non-opioid pain uptake improves, and the FDA approves a new T1D trial arm.
[27:10] All-In notes SpaceX and xAI on…
Website: telltales.substack.com

